Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  HUMAN FORMYLGLYCINE GENERATING ENZYME, C336S MUTANT, BROMIDE CO-CRYSTALLIZATION
 
Authors :  M. G. Rudolph, D. Roeser
Date :  29 Jun 06  (Deposition) - 01 May 07  (Release) - 13 Jul 11  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  1.64
Chains :  Asym./Biol. Unit :  P,X
Keywords :  Hydrolase Activator, Protein Binding, Formylglycin Generation, Post- Translational Modification, Endoplasmic Reticulum, Sulfatase (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  D. Roeser, B. Schmidt, A. Preusser-Kunze, M. G. Rudolph
Probing The Oxygen-Binding Site Of The Human Formylglycine-Generating Enzyme Using Halide Ions.
Acta Crystallogr. , Sect. D V. 63 621 2007
PubMed-ID: 17452787  |  Reference-DOI: 10.1107/S0907444907009961

(-) Compounds

Molecule 1 - SULFATASE-MODIFYING FACTOR 1
    ChainsX
    EngineeredYES
    Expression SystemHOMO SAPIENS
    Expression System CellFIBROSARCOMA CELLS
    Expression System CommonHUMAN
    Expression System Taxid9606
    FragmentRESIDUES 86-371
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymC-ALPHA-FORMYGLYCINE-GENERATING ENZYME 1
 
Molecule 2 - CTPSR
    ChainsP
    EngineeredYES
    Other DetailsTHE PEPTIDE WAS CHEMICALLY SYNTHESIZED.
    SyntheticYES

 Structural Features

(-) Chains, Units

  12
Asymmetric/Biological Unit PX

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (4, 20)

Asymmetric/Biological Unit (4, 20)
No.NameCountTypeFull Name
1BR15Ligand/IonBROMIDE ION
2CA2Ligand/IonCALCIUM ION
3CL1Ligand/IonCHLORIDE ION
4NAG2Ligand/IonN-ACETYL-D-GLUCOSAMINE

(-) Sites  (20, 20)

Asymmetric Unit (20, 20)
No.NameEvidenceResiduesDescription
01AC1SOFTWARENAG X:2 , THR X:134 , GLU X:137 , LYS X:138 , ASN X:141 , HOH X:1256BINDING SITE FOR RESIDUE NAG X 1
02AC2SOFTWARENAG X:1BINDING SITE FOR RESIDUE NAG X 2
03AC3SOFTWARETRP X:299 , SER X:333 , SER X:336 , CYS X:341 , ASN X:360 , HOH X:1318BINDING SITE FOR RESIDUE BR X 1001
04AC4SOFTWARELYS X:249 , HOH X:1306BINDING SITE FOR RESIDUE BR X 1002
05AC5SOFTWARELEU X:225 , HOH X:1310 , HOH X:1406BINDING SITE FOR RESIDUE BR X 1003
06AC6SOFTWAREARG X:236 , ASN X:241 , ARG X:242BINDING SITE FOR RESIDUE BR X 1004
07AC7SOFTWAREHOH X:1090 , HOH X:1116 , HOH X:1211 , HOH X:1286BINDING SITE FOR RESIDUE BR X 1005
08AC8SOFTWARECYS P:1 , TRP X:179 , TRP X:180 , TYR X:340BINDING SITE FOR RESIDUE BR X 1006
09AC9SOFTWARETHR X:219 , LYS X:253 , HOH X:1154BINDING SITE FOR RESIDUE BR X 1007
10BC1SOFTWAREARG X:224 , ASP X:368BINDING SITE FOR RESIDUE BR X 1008
11BC2SOFTWAREPRO X:202 , ASP X:203 , HIS X:204BINDING SITE FOR RESIDUE BR X 1009
12BC3SOFTWAREGLN X:262 , GLY X:263 , HIS X:337 , HOH X:1195 , HOH X:1340BINDING SITE FOR RESIDUE BR X 1010
13BC4SOFTWAREALA X:283 , PHE X:284 , HOH X:1335BINDING SITE FOR RESIDUE BR X 1011
14BC5SOFTWAREASN X:212 , PRO X:354 , HOH X:1114 , HOH X:1370BINDING SITE FOR RESIDUE BR X 1012
15BC6SOFTWARESER X:196 , THR X:197 , HIS X:200 , ARG X:201 , HOH X:1228BINDING SITE FOR RESIDUE BR X 1013
16BC7SOFTWARELEU X:239 , HIS X:240 , ARG X:242 , HOH X:1188BINDING SITE FOR RESIDUE BR X 1014
17BC8SOFTWAREGLU X:314BINDING SITE FOR RESIDUE BR X 1015
18BC9SOFTWAREGLU X:130 , ASN X:293 , GLY X:296 , ALA X:298 , GLU X:300 , HOH X:1048BINDING SITE FOR RESIDUE CA X 1016
19CC1SOFTWAREASN X:259 , ILE X:260 , ASP X:273 , PHE X:275 , HOH X:1024 , HOH X:1027BINDING SITE FOR RESIDUE CA X 1017
20CC2SOFTWARETRP X:299 , SER X:333 , SER X:336 , CYS X:341 , ASN X:360 , HOH X:1318BINDING SITE FOR RESIDUE CL X 1018

(-) SS Bonds  (3, 3)

Asymmetric/Biological Unit
No.Residues
1X:218 -X:365
2X:235 -X:346
3X:341 -P:1

(-) Cis Peptide Bonds  (2, 2)

Asymmetric/Biological Unit
No.Residues
1Ala X:114 -Pro X:115
2Phe X:265 -Pro X:266

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (13, 13)

Asymmetric/Biological Unit (13, 13)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_016053S155PSUMF1_HUMANDisease (MSD)137852850XS155P
02UniProtVAR_019051A177PSUMF1_HUMANDisease (MSD)  ---XA177P
03UniProtVAR_042602W179SSUMF1_HUMANDisease (MSD)757323641XW179S
04UniProtVAR_016054C218YSUMF1_HUMANDisease (MSD)137852854XC218Y
05UniProtVAR_019052R224WSUMF1_HUMANDisease (MSD)759888604XR224W
06UniProtVAR_019053N259ISUMF1_HUMANDisease (MSD)764215221XN259I
07UniProtVAR_019054P266LSUMF1_HUMANDisease (MSD)763243827XP266L
08UniProtVAR_016055A279VSUMF1_HUMANDisease (MSD)137852849XA279V
09UniProtVAR_016056C336RSUMF1_HUMANDisease (MSD)137852848XS336R
10UniProtVAR_016057R345CSUMF1_HUMANDisease (MSD)137852852XR345C
11UniProtVAR_016058A348PSUMF1_HUMANDisease (MSD)137852853XA348P
12UniProtVAR_016059R349QSUMF1_HUMANDisease (MSD)137852847XR349Q
13UniProtVAR_016060R349WSUMF1_HUMANDisease (MSD)137852846XR349W

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (0, 0)

(no "PROSITE Motif" information available for 2HI8)

(-) Exons   (9, 9)

Asymmetric/Biological Unit (9, 9)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000002729021aENSE00001901311chr3:4508965-4508660306SUMF1_HUMAN1-90901X:86-905
1.2ENST000002729022ENSE00000965223chr3:4494733-4494560174SUMF1_HUMAN91-148581X:91-14858
1.3ENST000002729023ENSE00001173781chr3:4491024-449095075SUMF1_HUMAN149-173251X:149-16214
1.4ENST000002729024ENSE00001173775chr3:4461830-446174883SUMF1_HUMAN174-201281X:175-20127
1.5ENST000002729025ENSE00001173770chr3:4459816-4459694123SUMF1_HUMAN201-242421X:201-24242
1.6ENST000002729026ENSE00001173766chr3:4458926-4458812115SUMF1_HUMAN242-280391X:242-28039
1.7ENST000002729027ENSE00001173758chr3:4452662-4452549114SUMF1_HUMAN281-318381X:281-31838
1.8ENST000002729028ENSE00001173755chr3:4418073-441801460SUMF1_HUMAN319-338201X:319-33820
1.9dENST000002729029dENSE00001072608chr3:4403938-44028301109SUMF1_HUMAN339-374361X:339-37133

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain P from PDB  Type:PROTEIN  Length:5
 aligned with ARSA_HUMAN | P15289 from UniProtKB/Swiss-Prot  Length:507

    Alignment length:5
           ARSA_HUMAN    69 CTPSR  73
               SCOP domains ----- SCOP domains
               CATH domains ----- CATH domains
               Pfam domains ----- Pfam domains
         Sec.struct. author ..... Sec.struct. author
                 SAPs(SNPs) ----- SAPs(SNPs)
                    PROSITE ----- PROSITE
                 Transcript ----- Transcript
                 2hi8 P   1 CTPSR   5

Chain X from PDB  Type:PROTEIN  Length:274
 aligned with SUMF1_HUMAN | Q8NBK3 from UniProtKB/Swiss-Prot  Length:374

    Alignment length:286
                                    95       105       115       125       135       145       155       165       175       185       195       205       215       225       235       245       255       265       275       285       295       305       315       325       335       345       355       365      
          SUMF1_HUMAN    86 LAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMCHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLP 371
               SCOP domains d2hi8x_ X: automated matches                                                                                                                                                                                                                                                                   SCOP domains
               CATH domains 2hi8X00 X:86-371 paralog of FGE (formylglycine-generating enzyme)                                                                                                                                                                                                                              CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....eeee..eeeee......hhhhh....eeeee..eeee....hhhhhhhhhhhhh..hhhhhhheeeee.hhh------------.....eeeee.........................hhhhhhhhhhhh.....hhhhhhhhhhh.............hhhhh...........................................eeeeeee.........ee..........eeee...................eee........ee...ee.... Sec.struct. author
             SAPs(SNPs) (1) ---------------------------------------------------------------------P---------------------P-S--------------------------------------Y-----W----------------------------------I------L------------V--------------------------------------------------------R--------C--PQ---------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W---------------------- SAPs(SNPs) (2)
                    PROSITE ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) 1.1a Exon 1.2  PDB: X:91-148 UniProt: 91-148                   Exon 1.3  PDB: X:149-162 Exon 1.4  PDB: X:175-201    ----------------------------------------Exon 1.6  PDB: X:242-280               Exon 1.7  PDB: X:281-318              Exon 1.8            Exon 1.9d  PDB: X:339-371         Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------------------------------------------------------------------------Exon 1.5  PDB: X:201-242 UniProt: 201-242 --------------------------------------------------------------------------------------------------------------------------------- Transcript 1 (2)
                 2hi8 X  86 LAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGML------------AAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMSHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLP 371
                                    95       105       115       125       135       145       155      |  -       175       185       195       205       215       225       235       245       255       265       275       285       295       305       315       325       335       345       355       365      
                                                                                                      162          175                                                                                                                                                                                                    

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 1)

Asymmetric/Biological Unit

(-) CATH Domains  (1, 1)

Asymmetric/Biological Unit
(-)
Class: Alpha Beta (26913)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 2HI8)

(-) Gene Ontology  (19, 23)

Asymmetric/Biological Unit(hide GO term definitions)
Chain P   (ARSA_HUMAN | P15289)
molecular function
    GO:0004065    arylsulfatase activity    Catalysis of the reaction: a phenol sulfate + H2O = a phenol + sulfate.
    GO:0005509    calcium ion binding    Interacting selectively and non-covalently with calcium ions (Ca2+).
    GO:0003824    catalytic activity    Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
    GO:0004098    cerebroside-sulfatase activity    Catalysis of the reaction: a cerebroside 3-sulfate + H2O = a cerebroside + sulfate.
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0008484    sulfuric ester hydrolase activity    Catalysis of the reaction: RSO-R' + H2O = RSOOH + R'H. This reaction is the hydrolysis of any sulfuric ester bond, any ester formed from sulfuric acid, O=SO(OH)2.
biological process
    GO:0006687    glycosphingolipid metabolic process    The chemical reactions and pathways involving glycosphingolipids, any compound with residues of sphingoid and at least one monosaccharide.
    GO:0008152    metabolic process    The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
    GO:0043687    post-translational protein modification    The process of covalently altering one or more amino acids in a protein after the protein has been completely translated and released from the ribosome.
cellular component
    GO:0005788    endoplasmic reticulum lumen    The volume enclosed by the membranes of the endoplasmic reticulum.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0043202    lysosomal lumen    The volume enclosed within the lysosomal membrane.
    GO:0005764    lysosome    A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.

Chain X   (SUMF1_HUMAN | Q8NBK3)
molecular function
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0016491    oxidoreductase activity    Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
    GO:0042803    protein homodimerization activity    Interacting selectively and non-covalently with an identical protein to form a homodimer.
biological process
    GO:0006687    glycosphingolipid metabolic process    The chemical reactions and pathways involving glycosphingolipids, any compound with residues of sphingoid and at least one monosaccharide.
    GO:0055114    oxidation-reduction process    A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
    GO:0043687    post-translational protein modification    The process of covalently altering one or more amino acids in a protein after the protein has been completely translated and released from the ribosome.
cellular component
    GO:0005783    endoplasmic reticulum    The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
    GO:0005788    endoplasmic reticulum lumen    The volume enclosed by the membranes of the endoplasmic reticulum.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    BR  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    CA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    CL  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
    BC1  [ RasMol ]  +environment [ RasMol ]
    BC2  [ RasMol ]  +environment [ RasMol ]
    BC3  [ RasMol ]  +environment [ RasMol ]
    BC4  [ RasMol ]  +environment [ RasMol ]
    BC5  [ RasMol ]  +environment [ RasMol ]
    BC6  [ RasMol ]  +environment [ RasMol ]
    BC7  [ RasMol ]  +environment [ RasMol ]
    BC8  [ RasMol ]  +environment [ RasMol ]
    BC9  [ RasMol ]  +environment [ RasMol ]
    CC1  [ RasMol ]  +environment [ RasMol ]
    CC2  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Ala X:114 - Pro X:115   [ RasMol ]  
    Phe X:265 - Pro X:266   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2hi8
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  ARSA_HUMAN | P15289
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  SUMF1_HUMAN | Q8NBK3
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  272200
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  ARSA_HUMAN | P15289
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  SUMF1_HUMAN | Q8NBK3
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        ARSA_HUMAN | P152891auk 1e1z 1e2s 1e33 1e3c 1n2k 1n2l 2aij 2aik
        SUMF1_HUMAN | Q8NBK31y1e 1y1f 1y1g 1y1h 1y1i 1y1j 1z70 2aft 2afy 2aii 2aij 2aik 2hib

(-) Related Entries Specified in the PDB File

(no "Related Entries Specified in the PDB File" available for 2HI8)